Skip to content
Clinical Trials – home
University Medical Center Hamburg-Eppendorf
Sponsor

University Medical Center Hamburg-Eppendorf

Germany Martinistrasse 52, Eppendorf, 20246 Hamburg, Germany

About the sponsor

Clinical research includes acute ischemic stroke care, with attention to thrombolysis strategies in patients using direct oral anticoagulants and to prevention of recurrent events in people with atrial fibrillation after stroke.

  • Acute ischemic stroke
  • Thrombolytic therapy
  • Atrial fibrillation
  • Secondary stroke prevention

These studies also address cardiovascular risk management in the setting of cerebrovascular disease.

About Specializations

University Medical Center Hamburg-Eppendorf runs clinical trials in conditions such as Ischaemic stroke, Plasma cell myeloma, Atrial fibrillation, Medulloblastoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

10 clinical trials

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tenecteplase
  • Sponsor:University Medical Center Hamburg-Eppendorf
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Flecainide Acetate
  • Sponsor:University Medical Center Hamburg-Eppendorf
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:Carboplatin
  • Sponsor:University Medical Center Hamburg-Eppendorf
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:University Medical Center Hamburg-Eppendorf
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Linezolid
  • Sponsor:University Medical Center Hamburg-Eppendorf
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Sponsor:University Medical Center Hamburg-Eppendorf
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:University Medical Center Hamburg-Eppendorf
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:University Medical Center Hamburg-Eppendorf
Countries:GermanyGermany
  • Participants:65+ years
  • Substances:Cytarabine
  • Sponsor:University Medical Center Hamburg-Eppendorf
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:University Medical Center Hamburg-Eppendorf

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.